RESUMEN
Objective: To evaluate the efficacy of transcatheter arterial embolization (TAE) in the treatment of neuroendocrine neoplasm liver metastases (NENLM), analyze the prognosis and related factors. Methods: Clinical data of NENLM patients treated with TAE in the First Affiliated Hospital of Nanjing Medical University from January 2018 to March 2022 were retrospectively analyzed. Objective response rate (ORR), disease control rate (DCR), and adverse event rate after TAE were evaluated according to the Response Evaluation Criteria In Solid Tumors and the Common Terminology Criteria for Adverse Events. The prognosis was evaluated by median overall survival (mOS) and median progression-free survival (mPFS). The survival curve was plotted by Kaplan-Meier method. Multivariate Cox regression was used to analyze prognostic factors. Results: A total of 39 NENLM patients were included in this study, aged (53.3±10.3) (23-74) years old, including 23 males and 16 females. Among them, 9 cases had functional neuroendocrine neoplasms. There were 31 cases with primary sites locating in the digestive system, 32 cases with WHO G1 and G2 primary sites, 27 cases with abundant blood supply for liver metastases and 13 cases with liver tumor load >50%. Thirty patients received treatment of long-acting somatostatin analogue(SSA). A total of 123 TAE were performed in 39 cases, with an ORR of 38.5% (15/39) and a DCR of 76.9% (30/39). There were no serious adverse events of level 4-5 during the perioperative period. The median follow-up was 38.7 (95%CI: 31.3-46.1) months, with mOS of 37.3(95%CI: 27.0-47.5) months and mPFS of 12.6 (95%CI: 7.1-18.1) months. Multivariate Cox regression analysis found that the combination of long-term SSA treatment was an influencing factor for overall survival of patients (HR=0.207, 95%CI: 0.076-0.567, P=0.002). Conclusions: TAE can effectively reduce the load of liver metastases in patients with NENLM, and the combination of long-term SSA treatment can improve the ovreall survival of patients.
Asunto(s)
Embolización Terapéutica , Neoplasias Hepáticas , Tumores Neuroendocrinos , Femenino , Masculino , Humanos , Adulto Joven , Adulto , Persona de Mediana Edad , Anciano , Estudios Retrospectivos , Pronóstico , Procedimientos Quirúrgicos Vasculares , Neoplasias Hepáticas/terapia , Tumores Neuroendocrinos/terapiaRESUMEN
Objective: To evaluate the short- and medium-term clinical efficacy of TIPS approach combined with AngioJet thrombus aspiration technology treatment in acute portal vein thrombosis. Methods: 63 cases with acute portal vein thrombosis treated in our center from May 2017 to July 2019 were studied retrospectively, including 49 males and 14 females, aged 35-61 (46 ± 5) years. TIPS approach (with/without) combined with Angiojet thrombus aspiration and gastroesophageal varices embolization was performed simultaneously according to the patient's condition. Regular follow-up for 3-33 (22 ± 3) months after surgery was used to observe the curative effect. Results: The technical success rate was 100%. Portal vein and superior mesenteric vein blood flow were returned to normal after the operation. Two cases of biliary tract injury were untreated. Simultaneously, two cases of intrahepatic arteriovenous fistula were treated with superselective arterial embolization. During the follow-up period, 47 cases (74.61%) had complete portal vein recanalization, 13 cases (20.63%) had partial recanalization, 3 cases (4.76%) had complete portal cavernoma, 7 cases (11.11%) had symptomatic hepatic encephalopathy, 1 case had received artificial liver treatment (1.59%), 1 case had peptic ulcer (11.11%), 6 cases (9.52%) had lost to follow-up, and there was no portal hypertension-related bleeding or death. Conclusion: TIPS approach combined with AngioJet thrombus aspiration technology is safe, effective and feasible in the treatment of acute portal vein thrombosis, and the short- and medium-term clinical effects are satisfactory.
Asunto(s)
Derivación Portosistémica Intrahepática Transyugular , Trombosis , Femenino , Humanos , Masculino , Vena Porta/cirugía , Estudios Retrospectivos , Tecnología , Resultado del TratamientoRESUMEN
AIM: To evaluate whether helical computed tomography (CT) images can be used to differentiate angiomyolipomas (AMLs) with minimal fat from papillary renal cell carcinomas (PRCCs) based on their morphological characteristics and enhancement features. MATERIALS AND METHODS: This retrospective study was approved by the institutional review board. Informed consent was waived. Forty-four patients (21 with AMLs with minimal fat and 23 with PRCCs) who underwent enhanced helical CT before total or partial nephrectomy were included. Two radiologists, who were blinded to the histopathology results, read the CT images and recorded the attenuation value, morphological characteristics, and enhancement features of the tumours, which were subsequently evaluated. An independent samples t-test, χ(2) test, and rank sum test were performed between the tumours. The predictive value of a CT finding was determined by multivariate logistic regression analysis. RESULTS: AML with minimal fat had an apparent female prevalence (p < 0.01). Intra-tumoural vessels were noted in 11 cases of AML with minimal fat and three PRCC cases (p < 0.01). The unenhanced attenuation characteristic was significantly different between the two diseases (p < 0.001). The absolute attenuation values (AAVs) and the corrected attenuation values (CAVs) of the AML with minimal fat group of unenhanced and two phases of enhanced images were greater compared with that of the PRCC group (p < 0.05). After contrast medium injection, the tumour enhancement value (TEV) of the AML with minimal fat group in the corticomedullary phase was greater than that of the PRCC group (p < 0.01). Most cases of both tumour types demonstrated early enhancement characteristics; the enhancement value of the AML with minimal fat group was greater compared with that of the PRCC group (p < 0.01). The unenhanced attenuation characteristic, intra-tumoural vessels, and CAVs of unenhanced and early excretory phase scans were valuable parameters to differentiate between AML with minimal fat and PRCC tumours by multivariate logistic regression analysis (p < 0.05 for all). CONCLUSION: The unenhanced attenuation characteristic, intra-tumoural vessels, and the attenuation values of unenhanced and early excretory phase scans are valuable parameters in differentiating AML with minimal fat from PRCC at CT.
Asunto(s)
Tejido Adiposo/diagnóstico por imagen , Angiomiolipoma/diagnóstico por imagen , Carcinoma de Células Renales/diagnóstico por imagen , Neoplasias Renales/diagnóstico por imagen , Tomografía Computarizada Espiral/métodos , Adulto , Anciano , Angiomiolipoma/cirugía , Diagnóstico Diferencial , Femenino , Humanos , Riñón/diagnóstico por imagen , Riñón/cirugía , Neoplasias Renales/cirugía , Masculino , Persona de Mediana Edad , Variaciones Dependientes del Observador , Intensificación de Imagen Radiográfica/métodos , Estudios Retrospectivos , Adulto JovenRESUMEN
Much concern has been raised about the increasing threat to air quality and human health due to ammonia (NH3) emissions from agricultural systems, which is associated with the enrichment of reactive nitrogen (N) in southern Asia (SA), home of more than 60% the world's population (i.e., the people of West, central, East, South, and Southeast Asia). Southern Asia consumed more than half of the global synthetic N fertilizer and was the dominant region for livestock waste production since 2004. Excessive N application could lead to a rapid increase of NH3 in the atmosphere, resulting in severe air and water pollution in this region. However, there is still a lack of accurate estimates of NH3 emissions from agricultural systems. In this study, we simulated the agricultural NH3 fluxes in SA by coupling the Bidirectional NH3 exchange module (Bi-NH3) from the Community Multi-scale Air Quality model with the Dynamic Land Ecosystem Model. Our results indicated that NH3 emissions were 21.3 ± 3.9 Tg N yr-1 from SA agricultural systems with a rapidly increasing rate of ~0.3 Tg N yr-2 during 1961-2014. Among the emission sources, 10.8 Tg N yr-1 was released from synthetic N fertilizer use, and 10.4 ± 3.9 Tg N yr-1 was released from manure production in 2014. Ammonia emissions from China and India together accounted for 64% of the total amount in SA during 2000-2014. Our results imply that the increased NH3 emissions associated with high N inputs to croplands would likely be a significant threat to the environment and human health unless mitigation efforts are applied to reduce these emissions.